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Abstract 
Background: Atrial fibrosis is a hallmark of atrial structural remodeling leading to the 
persistence of atrial fibrillation. Although fibroblasts play a major role in atrial fibrosis, 
their source in the adult atrium is unclear. We tested the hypothesis that endothelial cells 
contribute to fibroblast accumulation through an endothelial–mesenchymal transition in 
the atrium of patients with atrial fibrillation. 
Methods and Results: The study group consisted of patients with atrial fibrillation and 
valvular disease or atrial septal defect who underwent left atrial appendectomy during 
cardiac surgery (n = 38). The amount of fibrotic depositions in the left atrium positively 
correlated with left atrial dimension. Furthermore, snail and S100A4, indicative of 
endothelial–mesenchymal transition, were quantified in the left atrium using western 
blot analysis, which showed statistically significant correlations with left atrial 
dimension. Immunofluorescence assay of the left atrial tissue identified snail and 
S100A4 being expressed within the endocardium which is composed of CD31+ cells. 
The snail-positive endocardium also showed the expression of membrane type 1-matrix 
metalloproteinase. Immunofluorescence multi-labeling experiments identified that heat 
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shock protein 47, prolyl-4-hydroxylase, and procollagen type 1 co-localized with snail 
and S100A4 within the endothelial cells of the left atrium, indicating the mesenchymal 
phenotype to produce collagen.  
Conclusions: In this study, we showed that the endothelial–mesenchymal transition 
occurs in the atrium of patients with atrial fibrillation. This observation should help in 
constructing a novel therapeutic approach for preventing atrial structural remodeling.  
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Introduction 
The first occurrence of atrial fibrillation (AF) is believed to be paroxysmal in 
nature; it then gradually perpetuates and finally develops into permanent AF with the 
progression of atrial remodeling [1,2]. Atrial fibrosis is a hallmark of atrial structural 
remodeling and leads to electrophysiological impairment of the atrium and persistence 
of AF [3]. Although fibroblasts play a major role in atrial fibrosis, their source in the 
adult atrium is unclear, and specific anti-fibrotic therapies are not currently available in 
clinical settings. 
Formerly, adult fibroblasts were considered to have originated from embryonic 
mesenchymal cells [4,5]; these resident fibroblasts were believed to proliferate under 
pathological conditions. However, recent studies have shown that epithelial cells 
contribute to fibroblast accumulation through an epithelial–mesenchymal transition 
(EMT) in the kidney, lung, and liver, in addition to the proliferation of resident 
fibroblasts and bone marrow-derived fibroblasts [6]. Experiments in mice have 
demonstrated that endothelial cells associated with the microvasculature can also 
contribute to the formation of mesenchymal cells during the course of fibrosis via a 
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similar process known as endothelial–mesenchymal transition (EndMT) [7]. 
Herein, we tested the hypothesis that endothelial cells undergo EndMT in the 




The study group consisted of 38 patients with AF (14 paroxysmal AF, 24 
permanent AF) with valvular disease or atrial septal defect who underwent left atrial 
appendectomy during cardiac surgery. None of the patients had previous myocardial 
infarction, febrile disorders, systemic inflammatory diseases, malignancy, or chronic 
renal failure. During the cardiac surgery, atrial tissue samples were collected from all 
patients, and they were quickly frozen in liquid nitrogen and stored at −80 °C until use. 
This investigation conforms to the principles outlined in the Declaration of 
Helsinki. All patients gave written informed consent, and an institutional review board 
approved the study. 
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Histology and Immunohistochemistry 
Blocks of tissues were compound-embedded in an optimal cutting temperature 
and immediately frozen in liquid nitrogen after resection. Frozen cryostat sections (8 
μm thick) were cut, air-dried, fixed in acetone, and then evaluated with standard 
protocols for Masson’s trichrome staining. The images were digitized using a digital 
microscope (COOLSCOPE; Nikon). To quantify fibrotic deposition of the left atrium 
(LA), blue pixel content of the digitized photos was measured relative to the total tissue 
area using Image-Pro Plus (Media Cybernetics). 
Immunostaining was performed by Dako EnVision+ Systems (Dako) using the 
primary antibodies listed in Table 1. Immunofluorescence labeling for microscopy was 
performed by treatment with Alexia Fluor 488- or 568-conjugated goat anti-rabbit 
antibodies or goat anti-mouse antibodies (Molecular Probes, 1:500 dilution). 
Immunofluorescence-labeled samples were examined with Axio Imager M1 and 
digitized with Axio Cam MRC5. The green channel had an excitation of 488 nm and an 
emission of 525 nm. The red channel had an excitation of 594 nm and an emission of 
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620 nm. Lack of any cross-talk between the channels was established. Control 
experiments performed by incubation with secondary antibodies only did not show 
positive staining under the same experimental conditions. 
 
Western Blot Analysis 
Total proteins (5 µg) extracted from the left atrial appendages were fractionated 
using SDS-PAGE gels, and transferred onto Amersham Hybond-P PVDF Transfer 
Membrane (GE Health Care). The primary antibodies used in this study were displayed 
in Table 1.  The secondary antibodies used were goat anti-rabbit IgG HRP-linked 
antibody, horse anti-mouse IgG HRP-linked antibody, and goat anti-biotin HRP-linked 
antibody (all from Cell Signaling Technology). 
 
Statistical Analysis 
Data are expressed as mean ± SD. Statistical analyses were performed using 
GraphPad Prism 5.0 for Macintosh (GraphPad Software). Left atrial dimension (LAD) 
was compared with fibrosis, snail, and S100A4 using linear regression analysis. P < 
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Table 2 lists the clinical data of the patients who participated in this study. Their mean 
age was 63.8 ± 9.1 years and there was male predominance (53%); their mean AF 
duration was 72.0 months. Of all patients, 14 had paroxysmal AF and 24 had persistent 
AF. In most cases, left ventricular systolic function was preserved (mean left ventricular 
ejection fraction: 63.1 ± 10.1%) and LA was dilated (range: 41–80 mm; mean: 54.9 ± 
9.5 mm). Majority of the patients (82%) underwent cardiac surgery for mitral valve 
disease. 
 
Atrial Structural Remodeling and EndMT Markers 
Representative images of LA by Masson’s trichrome staining are shown in Fig 1A. 
The amount of fibrotic depositions in LA was positively correlated with LAD (y = 
0.3004x − 4.395, R2 = 0.3809, P < 0.0001, Fig 1B). Furthermore, the amount of snail 
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and S100A4, indicative of EndMT, in LA showed weak but statistically significant 
correlations with LAD (y = 0.1269x + 3.388, R2 = 0.1387, P = 0.0213 for snail, Fig 2A; 
and y = 0.3728x + 2.793, R2 = 0.1216, P = 0.0319 for S100A4, Fig 2B).  The amount 
of S100A4 was also positively correlated with the extent of fibrosis (y = 0.9012x + 
12.35, R2 = 0.1683, P = 0.0105, Fig 2D), whereas the amount of snail showed 
marginally insignificant correlation with the fibrosis (y = 0.1984x + 7.955, R2 = 
0.08028, P = 0.0847, Fig 2C). 
 
Localizations of EndMT-Related Molecules in the Atrium 
The immunofluorescence assay of the LA tissue revealed the expression of snail 
(Fig 3) and S100A4 (Fig 4) within the endocardium composed of CD31+ endothelial 
cells. The staining indicative of snail and S100A4 was positive in 23.7% and 19.3% of 
CD31+ cells, respectively. The snail-positive endocardium also showed the expression 
of membrane type 1-matrix metalloproteinase (MT1-MMP) (Fig 5). 
The co-expressions of heat shock protein 47 (HSP47), prolyl 4-hydroxylase 
(P4HD), procollagen type 1 (ProCL1) with snail and S100A4 within endothelial cells in 
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The following were the major findings of this study: (1) in the atrium of patients 
with AF, the endothelial cells expressed snail, S100A4, HSP47, P4HD, and ProCL1, 
suggesting a process of EndMT. (2) The expression levels of snail and S100A4 were 
positively correlated with LAD. 
 
Role of Fibroblasts in Developing AF 
Atrial structural remodeling, particularly fibrosis in which fibroblasts play a key 
role, is important in many forms of AF [8,9,10]. In our study population, the amount of 
fibrotic deposition in LA was correlated with LAD, which is a strong predictor of 
recurrence of AF after catheter ablation or drug therapy [2,11]. Interstitial fibrosis 
separates cardiomyocytes, which interferes with electric continuity and slows the 
electrical conduction and thereby causes the progression of AF to permanent forms [3]. 
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In addition, fibroblasts per se can electrically couple with cardiomyocytes and when 
their number increases, they promote reentry and/or ectopic activity [12]. Therefore, 
atrial fibroblasts are potentially a therapeutic target in AF. 
 
EndMT Process in AF 
EMT is a biological process that allows a polarized epithelial cell, which normally 
interacts with basement membrane, to undergo multiple biochemical changes that 
enable it to assume a mesenchymal cell phenotype, which includes enhanced migratory 
capacity, invasiveness, elevated resistance to apoptosis, and greatly increased 
production of components of the extracellular matrix [13]. A central event in EMT is the 
downregulation of membranous E-cadherin expression, which leads to the loss of cell–
cell contact and the consecutive progression of the cells toward a malignant phenotype 
[14]. Snail, a zinc-finger transcription factor, is a key EMT regulator [15]. Studies have 
shown that snail represses E-cadherin transcription by binding to the E-box site in the 
promoter of E-cadherin [16-18]. The completion of an EMT process is signaled by the 
degradation of underlying basement membrane by MMPs and the formation of a 
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mesenchymal cell that can migrate away from the epithelial layer in which it originated 
[13]. The co-expression of both snail and MT1-MMP within atrial endothelial cells in 
our study suggests an EndMT process in the human atrium. 
To gather more evidence that atrial endothelial cells undergo EndMT during AF 
progression, we performed immunofluorescence multi-labeling experiments using 
antibodies against snail, S100A4, HSP47, P4HD, and ProCL1. S100A4 [19], also 
known as fibroblast-specific protein 1 (FSP1) [20,21], is a member of the S100 
superfamily of EF-hand calcium-binding proteins. P4HD is an essential enzyme for the 
biosynthesis of procollagen [22] and HSP47 is an ER-resident stress protein that is 
believed to function as a molecular chaperone specific to the biosynthesis of 
procollagen [23,24]. We identified the co-expressions of these profibrotic molecules 
within the atrial endocardial cells, suggesting transition to fibroblast phenotype. 
 
Limitations 
The study has some limitations. First, it is still unknown whether there is a causal 
relationship between EndMT and AF as we could not obtain atrial samples from healthy 
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subjects. Second, we only collected samples of left atrial appendage; therefore, the 
present findings may not be representative of other areas of the atrium. 
 
Conclusions 
To the best of our knowledge, this is the first study to provide evidence that 
EndMT occurs in the atrium of patients with AF. Our findings should help researchers 
to construct a novel therapeutic approach for the prevention of atrial structural 
remodeling in the treatment of AF. 
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Fig 1. Relationship between left atrial dimension (LAD) and fibrosis in the left 
atrium (LA). A: Representative images of Masson’s trichrome staining. Fibrosis 
(blue-colored) was more prominent in larger LA. B: The amount of fibrotic depositions 
in LA was positively correlated with LAD. 
 
Fig 2. Western blot analysis of the left atrial tissue for snail and S100A4. A: The 
expression of snail showed statistically significant correlation with left atrial dimension 
(LAD). B: The expression of S100A4 also showed correlation with LAD. 
 
Fig 3. Immunofluorescence assay of left atrial tissue for snail and CD31. Snail was 
expressed within the endocardium composed of CD31+ endothelial cells. 
 
Fig 4. Immunofluorescence assay of left atrial tissue for S100A4 and CD31. S100A4 
was expressed within the endocardium composed of CD31+ endothelial cells. 
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Fig 5. Immunofluorescence assay of left atrial tissue for snail and membrane type 
1-matrix metalloproteinase (MT1-MMP). The snail-positive endocardium showed the 
expression of MT1-MMP. 
 
Fig 6. Immunofluorescence multi-labeling experiments using antibodies against 
snail, S100A4, heat shock protein 47 (HSP47), prolyl 4-hydroxylase (P4HD), and 
procollagen type 1 (ProCL1). Co-expressions of HSP47, P4HD, and ProCL1 with snail 
and S100A4 within left atrial endothelial cells were observed. 
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 Table 1. Antibodies used in this study. 
Antibody Manufacturer Cat# 
Snail1 + Snail2 Abcam ab85931 
S100A4 Abcam ab27957 
MT1-MMP DKF F-84 
Heat shock protein 47 Stressgen SPA-470 
Prolyl-4-hydroxylase Abcam ab44971 




CD31 Dako Cytomation N1596 
 
  

















1 M 36 66 MR 55 68 A, B, L, W 
 
2 M 63 15 MR 61 45 A, B, L, W 
 
3 M 63 12 AR 76 48 A, C, L, W 
 
4 M 69 27 ASD 60 47 B, L, W 
 
5 M 80 1 AS/MS 39 64 B, L, W 
 
6 M 71 10 MR 71 54 L, W 
 
7 F 57 1 ASD 77 41 B, L, W 
 
8 F 81 1 ASD 55 51 A, B, L, W 
 
9 F 50 12 AR 47 47 B, L, W 
 
10 F 58 13 AR/MR 69 50 C, L, W, AD 
 
11 F 56 1 AR 64 43 B, L, W 
 
12 M 76 61 MR 73 49 B, L, W 
 
13 F 68 1 MS 70 47 A, C, L, W 
 
14 F 63 1 MS 50 50 C, L, W 
         Per 
AF 
15 M 56 12 MR 65 43 A, B, L, W 
 
16 F 73 71 MR 57 62 A, L, W 
 
17 F 59 48 MR 64 56 
A, B, L, W, 
AD 
 
18 M 56 31 MR 57 45 
A, B, C, L, 
W 
 
19 F 49 12 MR 67 44 L, N, W 
 
20 M 63 26 MR 62 57 A, B, L, W 
 
21 M 59 28 MR 76 58 
A, C, L, W, 
AD 
 
22 F 73 117 MR 67 58 B, C, L, W 
 
23 M 77 180 MR 59 66 
A, C, D, L, 
W 
 
24 M 55 180 MR 51 60 A, C, L, W 
 
25 M 66 135 MR 72 61 A, B, W 
 
26 F 59 132 MS 56 67 A, L, W 
 
27 F 72 276 MS 67 77 A, L, W 
 
28 F 68 120 MS 73 69 L, W 
 
29 F 74 2 MR 76 57 L, W 
 
30 M 65 108 ASR/MS 58 49 B, L, W 
 
31 M 70 192 MS/TR 50 49 A, B, L, W 
 
32 M 71 36 MR 51 52 L, W 
 
33 F 61 240 MSR 66 80 L, W 
 
34 F 63 312 MSR/ASR/TR 80 56 C, L, W 
 
35 F 62 96 MS 61 58 B, C, L, W 
 
36 M 63 32 MR/ASD 75 53 A, L, W 
 
37 M 57 43 AR 46 59 
A, B, C, L, 
W 
 
38 M 64 84 AS/MR 74 45 A, B, L, W 
Par = paroxysmal; Per = permanent; LVEF = left ventricular ejection fraction; LAD = 
left atrial dimension; MR = mitral regurgitation; AR = aortic regurgitation; AS = aortic 
stenosis; MS = mitral stenosis; TR = tricuspid regurgitation; ASD = atrial septal defect; 
A = angiotensin-converting enzyme inhibitor or angiotensin receptor blockers; B = 
β-blockers; C = calcium channel blockers; L = loop diuretics; N = nitrates; W = 
warfarin; AD = anti-arrhythmic drug.  AF duration is defined as the time  
 
